Novo Nordisk is committed to Changing Possibilities in Haemophilia®, working towards a future where all peopleliving with haemophilia, with or without inhibitors, have the opportunity to lead the life they desire.
Changing Possibilities in Haemophilia® represents Novo Nordisk’s commitment to the whole of the haemophilia and rare bleeding disorder community. Driven by a vision and core ambitions our commitment links together all the company’s activities, from development of new treatments to support of community projects, which are aimed at improving the lives of people with haemophilia and allied bleeding disorders.
The Changing Possibilities in Haemophilia® programme has three overarching ambitions, to;
- Strengthen understanding of haemophilia in the broader society
- Improve access to diagnosis, care and treatment
- Advance treatment and care through innovation
Read more about our ambitions here.